REPATHA is a Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Amgen Usa Inc.. The primary component is Evolocumab.
Product ID | 72511-750_5c290345-517d-4a4f-8a6c-7b84f07e7033 |
NDC | 72511-750 |
Product Type | Human Prescription Drug |
Proprietary Name | REPATHA |
Generic Name | Evolocumab |
Dosage Form | Injection, Solution |
Route of Administration | SUBCUTANEOUS |
Marketing Start Date | 2018-10-09 |
Marketing Category | BLA / BLA |
Application Number | BLA125522 |
Labeler Name | Amgen USA Inc. |
Substance Name | EVOLOCUMAB |
Active Ingredient Strength | 140 mg/mL |
Pharm Classes | Antibodies, Monoclonal [CS], PCSK9 Inhibitor [EPC], PCSK9 Inhibitors [MoA] |
NDC Exclude Flag | N |
Listing Certified Through | 2023-12-31 |
Marketing Start Date | 2018-10-09 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | BLA |
Application Number | BLA125522 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | ML |
Marketing Start Date | 2018-10-09 |
Ingredient | Strength |
---|---|
EVOLOCUMAB | 140 mg/mL |
SPL SET ID: | cd61e902-166d-4aa6-9f3c-a18c1008d07e |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
55513-750 | REPATHA | Evolocumab |
55513-760 | REPATHA | Evolocumab |
55513-770 | REPATHA | Evolocumab |
72511-750 | REPATHA | Evolocumab |
72511-760 | REPATHA | Evolocumab |
72511-770 | REPATHA | REPATHA |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
REPATHA 86436098 not registered Dead/Abandoned |
Amgen Inc. 2014-10-27 |
REPATHA 86066934 4837298 Live/Registered |
Amgen Inc. 2013-09-17 |
REPATHA 76463628 not registered Dead/Abandoned |
Amgen Inc. 2002-11-01 |